How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
Food and Drug Administration granted approval for its Investigational Device Exemption, allowing the company to initiate the pivotal NANOCLAMP AF clinical study evaluating its nanosecond Pulsed Field Ablation Cardiac Surgery System for treating atrial fibrillation. This milestone marks the first advancement of pulsed field ablation technology into the cardiac surgical field, highlighting potential for improved patient outcomes through nonthermal ablation approaches. We'll explore how FDA approval for the NANOCLAMP AF study shapes Pulse Biosciences' investment narrative by expanding its clinical and commercial opportunity. Find companies with promising cash flow potential yet trading below their fair value What Is Pulse Biosciences' Investment Narrative? For anyone considering Pulse Biosciences as an investment, the latest FDA approval for the NANOCLAMP AF clinical study is a key development that reshapes both immediate catalysts and risk factors for the company. On one hand,
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor ConferencesBusiness Wire
- Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial ResultsBusiness Wire
PLSE
Earnings
- 11/5/25 - Beat
PLSE
Sec Filings
- 11/13/25 - Form 8-K
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PLSE's page on the SEC website